A Smolarska, I Pruszynska, W Wasylko, K Godlewska, M Markowska, A Rybak, J Botther, P Kucharzewska, J Nowakowska, J Szeliga, M Kubiak, M Gorczak, M Krol
Glioblastoma, the most common and aggressive type of brain tumor in adults, poses significant challenges in terms of treatment. Conventional approaches including surgery, chemotherapy, and radiotherapy have yielded limited success, with a median survival of approximately 15 months. However, extensive research into the biology of glioblastoma has identified molecular targets that can be exploited by newly developed drugs, leading to the emergence of precise personalized therapies. Several innovative treatment strategies are currently under development, aiming to enhance effectiveness while minimizing side effects...
June 2023: Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society